# RNN 1st Gen Model Edwards Lifesciences Corporation Surgical appliances & supplies

Stock predictor AI models:
66.67% successful of 21 deals
$ 111.09 Last close price
at 18-oct-2021


Model's trade recommendations 0.18% Return for period

-0.61% Annual return

$27.76B Market Cap

β 0.64  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 0.18%
52wk return 7.99%
52wk Range
Sortino ratio -0.05
Sharpe ratio -0.04
Norm. RMSE 0.95%
Downside risk 8.23%
Volatility 0.00%
  • STRONG BUY Analysts consensus recommendation

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.

Industry sector: Medical

Sector classification: Surgical appliances & supplies

Deep Learning based analysis and prediction model for Edwards Lifesciences Corporation (EW) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Oct. 2, 2015.

Market data for EW model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for EW.

Model is being retrained on a daily basis.

Float 207M
P/E 32.28
Shares Outstanding 211M
% Held by Insiders 1.84%
% Held by Institutions 83.03%
EPS (last reported FY) $3.80
EPS (last reported Q) $1.22
EPS, estimated (last reported Q) $1.10
Total revenues $3 B
Net income $1 B